Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

July 1, 2019; Volume 60,Issue 7
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Radojewski, Piotr

    1. You have access
      MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid Cancer
      Oussama ElMokh, Vincent Taelman, Piotr Radojewski, Matthias A. Roelli, Amandine Stoss, Rebecca A. Dumont, Matthias S. Dettmer, Wayne A. Phillips, Martin A. Walter and Roch-Philippe Charles
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 917-923; DOI: https://doi.org/10.2967/jnumed.118.216721
  2. Ramirez, Roberto

    1. You have access
      Advanced Imaging in Cardiac Sarcoidosis
      Roberto Ramirez, Maria Trivieri, Zahi A. Fayad, Amir Ahmadi, Jagat Narula and Edgar Argulian
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 892-898; DOI: https://doi.org/10.2967/jnumed.119.228130
  3. Rangger, Christine

    1. You have access
      DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use
      Maximilian Klingler, Dominik Summer, Christine Rangger, Roland Haubner, Julie Foster, Jane Sosabowski, Clemens Decristoforo, Irene Virgolini and Elisabeth von Guggenberg
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 1010-1016; DOI: https://doi.org/10.2967/jnumed.118.221283
  4. Reichel, Kathrin

    1. You have access
      Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes
      Cordula A. Jilg, Vanessa Drendel, H. Christian Rischke, Teresa I. Beck, Kathrin Reichel, Malte Krönig, Ulrich Wetterauer, Wolfgang Schultze-Seemann, Philipp T. Meyer and Werner Vach
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 971-977; DOI: https://doi.org/10.2967/jnumed.118.220541
  5. Reilly, Raymond M.

    1. You have access
      Immuno-PET to Optimize the Dose of Monoclonal Antibodies for Cancer Therapy: How Much Is Enough?
      Raymond M. Reilly
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 899-901; DOI: https://doi.org/10.2967/jnumed.119.225854
  6. Rijpkema, Mark

    1. You have access
      In Vitro and In Vivo Characterization of an 18F-AlF-Labeled PSMA Ligand for Imaging of PSMA-Expressing Xenografts
      Susanne Lütje, Gerben M. Franssen, Ken Herrmann, Otto C. Boerman, Mark Rijpkema, Martin Gotthardt and Sandra Heskamp
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 1017-1022; DOI: https://doi.org/10.2967/jnumed.118.218941
  7. Rischke, H. Christian

    1. You have access
      Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes
      Cordula A. Jilg, Vanessa Drendel, H. Christian Rischke, Teresa I. Beck, Kathrin Reichel, Malte Krönig, Ulrich Wetterauer, Wolfgang Schultze-Seemann, Philipp T. Meyer and Werner Vach
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 971-977; DOI: https://doi.org/10.2967/jnumed.118.220541
  8. Roelli, Matthias A.

    1. You have access
      MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid Cancer
      Oussama ElMokh, Vincent Taelman, Piotr Radojewski, Matthias A. Roelli, Amandine Stoss, Rebecca A. Dumont, Matthias S. Dettmer, Wayne A. Phillips, Martin A. Walter and Roch-Philippe Charles
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 917-923; DOI: https://doi.org/10.2967/jnumed.118.216721
  9. Rogowski, Paul

    1. You have access
      Impact of 68Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis
      Nina-Sophie Schmidt-Hegemann, Chukwuka Eze, Minglun Li, Paul Rogowski, Christian Schaefer, Christian Stief, Alexander Buchner, Constantinos Zamboglou, Wolfgang Peter Fendler, Ute Ganswindt, Clemens Cyran, Peter Bartenstein, Claus Belka and Harun Ilhan
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 963-970; DOI: https://doi.org/10.2967/jnumed.118.220855
  10. Rosenspire, Karen C.

    1. You have access
      In Memoriam: Monte Blau, PhD, 1926–2019
      Hank F. Kung, Karen C. Rosenspire and Robert H. Mach
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 11N-12N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 60 (7)
Journal of Nuclear Medicine
Vol. 60, Issue 7
July 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors
  • P2X7 PET Radioligand 18F-PTTP for Differentiation of Lung Tumor from Inflammation
  • Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer
  • Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire